| 1. |
- Asare, Fredrick, 1979, et al.
(författare)
-
Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome.
- 2012
-
Ingår i: Current gastroenterology reports. - : Springer Science and Business Media LLC. - 1534-312X .- 1522-8037. ; 14:4, s. 283-9
-
Forskningsöversikt (refereegranskat)abstract
- Complimentary alternative treatment regimens are widely used in irritable bowel syndrome (IBS), but the evidence supporting their use varies. For psychological treatment options, such as cognitive behavioral therapy, mindfulness, gut-directed hypnotherapy, and psychodynamic therapy, the evidence supporting their use in IBS patients is strong, but the availability limits their use in clinical practice. Dietary interventions are commonly included in the management of IBS patients, but these are primarily based on studies assessing physiological function in relation to dietary components, and to a lesser degree upon research examining the role of dietary components in the therapeutic management of IBS. Several probiotic products improve a range of symptoms in IBS patients. Physical activity is of benefit for health in general and recent data implicates its usefulness also for IBS patients. Acupuncture does not seem to have an effect beyond placebo in IBS. A beneficial effect of some herbal treatments has been reported.
|
|
| 2. |
- Büsch, K, et al.
(författare)
-
Impact of inflammatory bowel disease on disability
- 2014
-
Ingår i: Current gastroenterology reports. - : Springer Science and Business Media LLC. - 1534-312X .- 1522-8037. ; 16:10, s. 414-
-
Tidskriftsartikel (refereegranskat)
|
|
| 3. |
- Öhman, Lena, 1967, et al.
(författare)
-
Intestinal microbiota and its role in irritable bowel syndrome (IBS).
- 2013
-
Ingår i: Current gastroenterology reports. - : Springer Science and Business Media LLC. - 1534-312X .- 1522-8037. ; 15:5
-
Forskningsöversikt (refereegranskat)abstract
- Gut microbiota alterations are increasingly being recognized as an important factor in the pathogenesis and pathophysiology of Irritable bowel syndrome (IBS). The onset of IBS symptoms after a bout of gastroenteritis comprises one of the strongest indications for the importance of gut microbiota for IBS. Moreover, recent studies have identified several susceptibility genes for IBS involved in the innate immunity and recognition of bacteria but also maintaining the integrity of the intestinal barrier. During recent years, it has also been demonstrated that IBS patients, or subgroups thereof, may have an altered microbiota composition relative to healthy individuals, mainly based on the analysis of fecal microbiota. Moreover, a positive effect of treatment with non-absorbable antibiotics and probiotics in IBS provides further indirect support for the relevance of gut microbiota alterations in IBS.
|
|
